Advertisement

Topics

Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

13:01 EDT 14 Mar 2018 | BioPortfolio Report Blog

Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP Pipeline Review, H1 2018


Summary


According to the recently published report 'Cholesteryl Ester Transfer Protein Pipeline Review, H1 2018'; Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes.


Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP Cholesteryl ester transfer protein CETP, also called plasma lipid transfer protein is a plasma protein that promotes the transfer of cholesteryl esters from antiatherogenic HDLs to proatherogenic apolipoprotein B apoBcontaining lipoproteins, including VLDLs, VLDL remnants, IDLs, and LDLs. A deficiency of CETP is associated with increased HDL levels and decreased LDL levels, a profile that is typically antiatherogenic.


The report 'Cholesteryl Ester Transfer Protein Pipeline Review, H1 2018' outlays comprehensive information on the Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.


It also reviews key players involved in Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1, 1 and 1 respectively.


Similarly, the universities portfolio in Preclinical stages comprises 2 molecules, respectively. Report covers products from therapy areas Cardiovascular and Metabolic Disorders which include indications Dyslipidemia, Acute Coronary Syndrome, Atherosclerosis, Cardiovascular Disease, Coronary Disease and Hyperlipidemia.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP

The report reviews Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP targeted therapeutics and enlists all their major and minor projects

The report assesses Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Cholesteryl Ester Transfer Protein Lipid Transfer Protein I or CETP Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...